Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586021 · ClinicalTrials.gov registry record · NA
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
A NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endoron Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06586021: Recruiting NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endoron Medical.
NCT06586021 is a NA study of Abdominal Aortic Aneurysm (AAA) that is actively recruiting participants, run by Endoron Medical. The registered enrollment target is 25 participants, below the 180-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06586021, a NA study of Abdominal Aortic Aneurysm (AAA), is actively recruiting participants, sponsored by Endoron Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
Primary Outcome
The EFS does not have defined primary endpoints nor any powered endpoints. The SEAL Study is not hypothesis driven. All endpoints will be analyzed descriptively
Conditions Studied
Interventions
- DEVICE Aortoseal Endostapling System
Study Locations (1)
Virginia
- Sentara Health Research Center - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2029-11-01 |
| Phase | NA |
What NCT06586021 shows while recruiting
NCT06586021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 180-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Abdominal Aortic Aneurysm (AAA) appearing as the primary indexed condition, and to 1 intervention - of which Aortoseal Endostapling System is the first listed.
NCT06586021 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06586021 about?
NCT06586021 is a clinical study titled "Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall". The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
What is the current status of trial NCT06586021?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-02-06. Estimated completion is 2029-11-01.
What conditions does trial NCT06586021 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm (AAA).
What interventions are being tested in trial NCT06586021?
The interventions under investigation include: Aortoseal Endostapling System (DEVICE).
Who is sponsoring clinical trial NCT06586021?
This trial is sponsored by Endoron Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06586021 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm (AAA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI